Subcutaneous Immunoglobulins Market 2027 By Application, End User and Geography | The Insight Partners

Subcutaneous Immunoglobulins Market to 2027 - Global Analysis and Forecasts By Application (Primary Immunodeficiency Diseases, Secondary Immunodeficiency Diseases and Other Applications); End User (Hospitals, Clinics and Homecare Settings) and Geography

Report Code: TIPRE00006207 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Immunoglobulins also known as antibodies are used for the treatment of primary immune deficiencies among children as well as adults. Subcutaneous Immunoglobulin infusions are administered by injecting immunoglobulin into fatty tissue below the layer of skin. These immunoglobulins can be given even at home, with the help of a mechanical infusion pump or by rapid push. Subcutaneous Immunoglobulins are considered as a boon for the patients with compromised immune system.

MARKET DYNAMICS

The subcutaneous immunoglobulins market is anticipated to grow in the forecast, owing to rise in the prevalence of autoimmune disorders as well as the availability of supportive government initiatives. In addition, the innovations in administration of subcutaneous immunoglobulin is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Subcutaneous Immunoglobulins Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of subcutaneous immunoglobulins market with detailed market segmentation by application, end user and geography. The global subcutaneous immunoglobulins market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading subcutaneous immunoglobulins market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global subcutaneous immunoglobulins market is segmented on the basis of application and end user. Based on application, the market is segmented as, primary immunodeficiency diseases, secondary immunodeficiency diseases and other applications. The subcutaneous immunoglobulins market is categorized based on end user such as, hospitals, clinics and homecare settings.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global subcutaneous immunoglobulins market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous immunoglobulins market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting subcutaneous immunoglobulins market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous immunoglobulins market in these regions.

MARKET PLAYERS

The reports cover key developments in the subcutaneous immunoglobulins market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from subcutaneous immunoglobulins market are anticipated to lucrative growth opportunities in the future with the rising demand for subcutaneous immunoglobulins market in the global market. Below mentioned is the list of few companies engaged in the subcutaneous immunoglobulins market.

The report also includes the profiles of key subcutaneous immunoglobulins market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Octapharma
- Kedrion Biopharma Inc.
- Grifols, S.A.
- CSL Behring
- Shire
- Biotest AG
- Bio Products Laboratory Ltd.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Subcutaneous Immunoglobulins Market - By Application
1.3.2 Subcutaneous Immunoglobulins Market - By End User
1.3.3 Subcutaneous Immunoglobulins Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SUBCUTANEOUS IMMUNOGLOBULINS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SUBCUTANEOUS IMMUNOGLOBULINS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SUBCUTANEOUS IMMUNOGLOBULINS MARKET - GLOBAL MARKET ANALYSIS
6.1. SUBCUTANEOUS IMMUNOGLOBULINS - GLOBAL MARKET OVERVIEW
6.2. SUBCUTANEOUS IMMUNOGLOBULINS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
?
7. SUBCUTANEOUS IMMUNOGLOBULINS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. PRIMARY IMMUNODEFICIENCY DISEASES
7.3.1. Overview
7.3.2. Primary Immunodeficiency Diseases Market Forecast and Analysis
7.4. SECONDARY IMMUNODEFICIENCY DISEASES
7.4.1. Overview
7.4.2. Secondary Immunodeficiency Diseases Market Forecast and Analysis
7.5. OTHER APPLICATIONS
7.5.1. Overview
7.5.2. Other Applications Market Forecast and Analysis
8. SUBCUTANEOUS IMMUNOGLOBULINS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. HOMECARE SETTINGS
8.5.1. Overview
8.5.2. Homecare Settings Market Forecast and Analysis
9. SUBCUTANEOUS IMMUNOGLOBULINS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Subcutaneous Immunoglobulins Market Overview
9.1.2 North America Subcutaneous Immunoglobulins Market Forecasts and Analysis
9.1.3 North America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Application
9.1.4 North America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By End User
9.1.5 North America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Countries
9.1.5.1 United States Subcutaneous Immunoglobulins Market
9.1.5.1.1 United States Subcutaneous Immunoglobulins Market by Application
9.1.5.1.2 United States Subcutaneous Immunoglobulins Market by End User
9.1.5.2 Canada Subcutaneous Immunoglobulins Market
9.1.5.2.1 Canada Subcutaneous Immunoglobulins Market by Application
9.1.5.2.2 Canada Subcutaneous Immunoglobulins Market by End User
9.1.5.3 Mexico Subcutaneous Immunoglobulins Market
9.1.5.3.1 Mexico Subcutaneous Immunoglobulins Market by Application
9.1.5.3.2 Mexico Subcutaneous Immunoglobulins Market by End User
9.2. EUROPE
9.2.1 Europe Subcutaneous Immunoglobulins Market Overview
9.2.2 Europe Subcutaneous Immunoglobulins Market Forecasts and Analysis
9.2.3 Europe Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Application
9.2.4 Europe Subcutaneous Immunoglobulins Market Forecasts and Analysis - By End User
9.2.5 Europe Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Subcutaneous Immunoglobulins Market
9.2.5.1.1 Germany Subcutaneous Immunoglobulins Market by Application
9.2.5.1.2 Germany Subcutaneous Immunoglobulins Market by End User
9.2.5.2 France Subcutaneous Immunoglobulins Market
9.2.5.2.1 France Subcutaneous Immunoglobulins Market by Application
9.2.5.2.2 France Subcutaneous Immunoglobulins Market by End User
9.2.5.3 Italy Subcutaneous Immunoglobulins Market
9.2.5.3.1 Italy Subcutaneous Immunoglobulins Market by Application
9.2.5.3.2 Italy Subcutaneous Immunoglobulins Market by End User
9.2.5.4 Spain Subcutaneous Immunoglobulins Market
9.2.5.4.1 Spain Subcutaneous Immunoglobulins Market by Application
9.2.5.4.2 Spain Subcutaneous Immunoglobulins Market by End User
9.2.5.5 United Kingdom Subcutaneous Immunoglobulins Market
9.2.5.5.1 United Kingdom Subcutaneous Immunoglobulins Market by Application
9.2.5.5.2 United Kingdom Subcutaneous Immunoglobulins Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Subcutaneous Immunoglobulins Market Overview
9.3.2 Asia-Pacific Subcutaneous Immunoglobulins Market Forecasts and Analysis
9.3.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Subcutaneous Immunoglobulins Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Subcutaneous Immunoglobulins Market
9.3.5.1.1 Australia Subcutaneous Immunoglobulins Market by Application
9.3.5.1.2 Australia Subcutaneous Immunoglobulins Market by End User
9.3.5.2 China Subcutaneous Immunoglobulins Market
9.3.5.2.1 China Subcutaneous Immunoglobulins Market by Application
9.3.5.2.2 China Subcutaneous Immunoglobulins Market by End User
9.3.5.3 India Subcutaneous Immunoglobulins Market
9.3.5.3.1 India Subcutaneous Immunoglobulins Market by Application
9.3.5.3.2 India Subcutaneous Immunoglobulins Market by End User
9.3.5.4 Japan Subcutaneous Immunoglobulins Market
9.3.5.4.1 Japan Subcutaneous Immunoglobulins Market by Application
9.3.5.4.2 Japan Subcutaneous Immunoglobulins Market by End User
9.3.5.5 South Korea Subcutaneous Immunoglobulins Market
9.3.5.5.1 South Korea Subcutaneous Immunoglobulins Market by Application
9.3.5.5.2 South Korea Subcutaneous Immunoglobulins Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Subcutaneous Immunoglobulins Market Overview
9.4.2 Middle East and Africa Subcutaneous Immunoglobulins Market Forecasts and Analysis
9.4.3 Middle East and Africa Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Subcutaneous Immunoglobulins Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Subcutaneous Immunoglobulins Market
9.4.5.1.1 South Africa Subcutaneous Immunoglobulins Market by Application
9.4.5.1.2 South Africa Subcutaneous Immunoglobulins Market by End User
9.4.5.2 Saudi Arabia Subcutaneous Immunoglobulins Market
9.4.5.2.1 Saudi Arabia Subcutaneous Immunoglobulins Market by Application
9.4.5.2.2 Saudi Arabia Subcutaneous Immunoglobulins Market by End User
9.4.5.3 U.A.E Subcutaneous Immunoglobulins Market
9.4.5.3.1 U.A.E Subcutaneous Immunoglobulins Market by Application
9.4.5.3.2 U.A.E Subcutaneous Immunoglobulins Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Subcutaneous Immunoglobulins Market Overview
9.5.2 South and Central America Subcutaneous Immunoglobulins Market Forecasts and Analysis
9.5.3 South and Central America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Application
9.5.4 South and Central America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By End User
9.5.5 South and Central America Subcutaneous Immunoglobulins Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Subcutaneous Immunoglobulins Market
9.5.5.1.1 Brazil Subcutaneous Immunoglobulins Market by Application
9.5.5.1.2 Brazil Subcutaneous Immunoglobulins Market by End User
9.5.5.2 Argentina Subcutaneous Immunoglobulins Market
9.5.5.2.1 Argentina Subcutaneous Immunoglobulins Market by Application
9.5.5.2.2 Argentina Subcutaneous Immunoglobulins Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. SUBCUTANEOUS IMMUNOGLOBULINS MARKET, KEY COMPANY PROFILES
11.1. OCTAPHARMA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. KEDRION BIOPHARMA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GRIFOLS, S.A.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CSL BEHRING
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SHIRE
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIOTEST AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIO PRODUCTS LABORATORY LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Octapharma
2. Kedrion Biopharma Inc.
3. Grifols, S.A.
4. CSL Behring
5. Shire
6. Biotest AG
7. Bio Products Laboratory Ltd.